###begin article-title 0
###xml 90 99 <span type="species:ncbi:7955">zebrafish</span>
Glycogen synthase kinase 3alpha and 3beta have distinct functions during cardiogenesis of zebrafish embryo
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Glycogen synthase kinase 3 (GSK3) encodes a serine/threonine protein kinase, is known to play roles in many biological processes. Two closely related GSK3 isoforms encoded by distinct genes: GSK3alpha (51 kDa) and GSK3beta (47 kDa). In previously studies, most GSK3 inhibitors are not only inhibiting GSK3, but are also affecting many other kinases. In addition, because of highly similarity in amino acid sequence between GSK3alpha and GSK3beta, making it difficult to identify an inhibitor that can be selective against GSK3alpha or GSK3beta. Thus, it is relatively difficult to address the functions of GSK3 isoforms during embryogenesis. At this study, we attempt to specifically inhibit either GSK3alpha or GSK3beta and uncover the isoform-specific roles that GSK3 plays during cardiogenesis.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 11 21 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 25 34 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 112 121 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 127 135 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 328 337 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 343 351 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 432 442 411 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 519 528 494 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 725 734 697 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 745 750 714 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 764 773 733 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 879 888 845 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 932 938 895 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">axin1 </italic>
###xml 942 945 905 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apc</italic>
###xml 945 949 908 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mcr </italic>
###xml 945 949 908 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>mcr </italic></sup>
###xml 1095 1105 1052 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 1141 1150 1094 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
We blocked gsk3alpha and gsk3beta translations by injection of morpholino antisense oligonucleotides (MO). Both gsk3alpha- and gsk3beta-MO-injected embryos displayed similar morphological defects, with a thin, string-like shaped heart and pericardial edema at 72 hours post-fertilization. However, when detailed analysis of the gsk3alpha- and gsk3beta-MO-induced heart defects, we found that the reduced number of cardiomyocytes in gsk3alpha morphants during the heart-ring stage was due to apoptosis. On the contrary, gsk3beta morphants did not exhibit significant apoptosis in the cardiomyocytes, and the heart developed normally during the heart-ring stage. Later, however, the heart positioning was severely disrupted in gsk3beta morphants. bmp4 expression in gsk3beta morphants was up-regulated and disrupted the asymmetry pattern in the heart. The cardiac valve defects in gsk3beta morphants were similar to those observed in axin1 and apcmcr mutants, suggesting that GSK3beta might play a role in cardiac valve development through the Wnt/beta-catenin pathway. Finally, the phenotypes of gsk3alpha mutant embryos cannot be rescued by gsk3beta mRNA, and vice versa, demonstrating that GSK3alpha and GSK3beta are not functionally redundant.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 259 268 <span type="species:ncbi:7955">zebrafish</span>
We conclude that (1) GSK3alpha, but not GSK3beta, is necessary in cardiomyocyte survival; (2) the GSK3beta plays important roles in modulating the left-right asymmetry and affecting heart positioning; and (3) GSK3alpha and GSK3beta play distinct roles during zebrafish cardiogenesis.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 151 157 <span type="species:ncbi:4932">yeasts</span>
Glycogen synthase kinase 3 (GSK3) encodes a multifunctional serine/threonine protein kinase, which is ubiquitously expressed in organisms ranging from yeasts to mammals [1-3]. GSK3 is, therefore, very important in the cellular signaling network. In addition to playing pivotal roles in the canonical Wnt and PI3K-PKB/AKT pathways, it has been shown to phosphorylate glycogen synthase, eLF2B, NFAT, c-jun, CyclinD1, NF-kB, as well as many others [4]. GSK3 is involved in many biological processes, including cell survival, tumorigenesis, and developmental patterning.
###end p 9
###begin p 10
###xml 113 114 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 281 282 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 449 450 431 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 451 452 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 379 385 <span type="species:ncbi:9606">humans</span>
There are two closely related GSK3 isoforms encoded by distinct genes: GSK3alpha (51 kDa) and GSK3beta (47 kDa) [5]. The difference in size is due to a glycine-rich extension at the N-terminus of GSK3alpha. GSK3alpha and GSK3beta are highly homologous within their kinase domains [6]. Homologues of GSK3 isoforms from species as distant from each other as flies, zebrafishes and humans display over 90% sequence similarity within the kinase domain [7,8].
###end p 10
###begin p 11
###xml 165 166 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 167 168 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 169 170 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 171 173 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 176 185 169 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 385 389 364 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">S6K </sup>
###xml 390 392 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 393 395 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 490 492 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 580 582 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 583 585 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 698 700 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 701 703 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 498 504 <span type="species:ncbi:9606">humans</span>
###xml 640 643 <span type="species:ncbi:10116">rat</span>
Despite that GSK3alpha and GSK3beta share common substrates, their expression patterns, substrate preferences, regulation, and cellular functions are not identical [1,6,9,10]. In vitro study reveals that GSK3alpha and GSK3beta are inactivated by phosphorylation of a specific N-terminal serine residue (Ser-21 in GSK3alpha; Ser-9 in GSK3beta) catalyzed by either MAPKAP kinase-1/or p70S6K [11,12], whereas protein kinase C phosphorylates and partially inhibits GSK3beta, but not GSK3alpha [13]. In humans, only GSK3alpha is deactivated by insulin during physiological conditions [14,15], whereas supraphysiological insulin injection in the rat leads to deactivation of both GSK3alpha and GSK3beta [15,16]. Although differential regulations by the two isoforms of GSK3 were proposed, the exact roles of GSK3alpha and GSK3beta and endogenous targets of such regulation remain to be investigated.
###end p 11
###begin p 12
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 469 471 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 563 572 542 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 576 583 555 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Several groups have identified small-molecule GSK3 inhibitors [17,18]. Most drugs bind to the ATP pocket of GSK3 and compete with ATP. However, these inhibitors are not only inhibiting GSK3, but are also affecting CDK kinase (2 and 5) and many other kinases. In addition, there appears to be only a single amino acid difference (Glu196 in GSK3alpha, Asp133 in GSK3beta), making it difficult to identify an inhibitor that can be selective against GSK3alpha or GSK3beta [19]. This finding is why it is difficult to analyze the exact roles of GSK3alpha and GSK3beta in vitro and in vivo.
###end p 12
###begin p 13
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 397 399 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 405 412 399 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 427 436 421 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 491 493 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 661 663 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 664 666 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 773 782 764 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 863 864 851 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 249 264 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 405 412 <span type="species:ncbi:8355">Xenopus</span>
###xml 590 595 <span type="species:ncbi:9606">women</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
Recent years, numerous studies indicate that GSK3 negatively regulates cardiac hypertrophy [20-22]. Despite that GSK3beta functions as a negative regulator of cardiac hypertrophy, GSK3 also plays an important role in regulating cardiac development. Transgenic mice over-expressing GSK3beta in the heart have impairments of postnatal cardiomyocyte growth and abnormal cardiac contractile function [23]. In Xenopus, injection of gsk3beta mRNA in embryos induces expression of Nkx2.5 and Tbx5 [24]. Oral treatment with lithium, a mood-stabilizing drug that is inhibitory for GSK3, in pregnant women showed a higher incidence of congenital heart defects in babies [25-27]. These findings prove that GSK3 might be involved in heart development. Unfortunately, disruption of the gsk3beta gene in mice results in embryonic lethality caused by severe liver degeneration [9], and no report is available to demonstrate that cardiac defects are happened in GSK3beta mutants. Thus, whether the roles of GSK3alpha and GSK3beta in different species are conserved remain to be investigated. Moreover, the roles of GSK3 in cardiac development are still unclear. Also, whether GSK3alpha and GSK3beta play similar roles in heart development is ambiguous.
###end p 13
###begin p 14
###xml 116 117 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 34 43 <span type="species:ncbi:7955">zebrafish</span>
###xml 82 91 <span type="species:ncbi:7955">zebrafish</span>
###xml 167 176 <span type="species:ncbi:7955">zebrafish</span>
###xml 268 277 <span type="species:ncbi:7955">zebrafish</span>
###xml 309 318 <span type="species:ncbi:7955">zebrafish</span>
###xml 447 456 <span type="species:ncbi:7955">zebrafish</span>
We have previously identified two zebrafish homologues related to mammalian GSK3: zebrafish GSK3alpha and GSK3beta [8]. In this report, we have taken advantage of the zebrafish system to address the distinct roles of GSK3alpha and GSK3beta during heart development of zebrafish. Our findings suggest that, in zebrafish, GSK3alpha, but not GSK3beta, is necessary in cardiomyocyte survival; whereas the GSK3beta isoform plays important roles during zebrafish cardiogenesis, modulating the left-right asymmetry and affecting heart positioning.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
###xml 13 23 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 27 36 23 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
Knockdown of gsk3alpha and gsk3beta display similar heart defects in the embryos
###end title 16
###begin p 17
###xml 72 81 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 87 95 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 146 156 139 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 160 168 149 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 227 237 213 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 243 251 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 498 508 470 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 514 523 482 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 554 555 519 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 35 44 <span type="species:ncbi:7955">zebrafish</span>
To address the role of GSK3 during zebrafish cardiogenesis, we designed gsk3alpha- and gsk3beta-MO for specifically inhibiting the translation of gsk3alpha and gsk3beta, respectively. When the protein lysate was extracted from gsk3alpha - and gsk3beta-MO-injected embryos at 24 hours postfertilization (hpf), Western blot analysis was performed by using isoform-specific antibodies. Results showed that the protein levels of GSK3alpha and GSK3beta were largely reduced in the protein extracts from gsk3alpha - and gsk3beta -morphants, respectively (Fig. 1), suggesting that the MOs we designed in this study were isoform-specific.
###end p 17
###begin p 18
###xml 36 45 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 51 60 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 0 159 0 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Injection of translation inhibitors <italic>gsk3&#945;</italic>- and <italic>gsk3&#946; </italic>-MO into embryos can specifically reduce the protein levels of GSK3&#945; and GSK3&#946;, respectively</bold>
###xml 591 601 559 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 607 616 571 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 207 216 <span type="species:ncbi:7955">zebrafish</span>
Injection of translation inhibitors gsk3alpha- and gsk3beta -MO into embryos can specifically reduce the protein levels of GSK3alpha and GSK3beta, respectively. The total protein lysate extracted from seven zebrafish embryos at 24 hpf was loaded on each lane and analyzed by western blot. The antibody used is indicated in the left of each blot. Anti-GSK3 antibody enables to recognize both GSK3alpha and GSK3beta proteins; anti-alpha-tubulin antibody was used as a loading control. The protein levels of GSK3alpha and GSK3beta were reduced greatly in the protein lysates extracted from the gsk3alpha - and gsk3beta -MO-injected embryos, respectively.
###end p 18
###begin p 19
###xml 60 69 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 75 83 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 206 217 199 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F, G, I, J</xref>
###xml 420 429 413 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 435 443 424 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 494 504 480 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 549 558 531 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 574 582 553 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B, C, F</xref>
###xml 587 592 566 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D, G</xref>
###xml 613 623 592 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 699 701 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 739 749 714 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 811 813 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 832 842 803 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 846 855 813 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 1055 1064 1019 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 1070 1078 1030 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 1089 1090 1046 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1108 1117 1065 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 1259 1268 1212 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 1361 1369 1310 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 1467 1475 1413 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 1586 1590 1529 1533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3</italic>
###xml 96 105 <span type="species:ncbi:7955">zebrafish</span>
###xml 456 465 <span type="species:ncbi:7955">zebrafish</span>
Similar morphological defects of the heart were observed in gsk3alpha- and gsk3beta-MO-injected zebrafish embryos at 72 hpf, such as a thin and string-like shape, pericardial edema, and blood pooling (Fig. 2F, G, I, J). These defects occurred initially in some 2 days postfertilization (dpf) morphants, and then were predominantly observed in most 3- and 4-dpf morphants. Although the heart defects were similar between gsk3alpha- and gsk3beta-MO-injected zebrafish embryos, the defects of the gsk3alpha morphants were more severe than those of the gsk3beta morphants (Fig. 2B, C, F vs. 2D, G). Around 40% of the gsk3alpha morphant defects were lethal due to an absent body axis during 24 hpf (Fig. 2B), and the remainder of the surviving gsk3alpha morphants suffered from an incomplete formation of axis (Fig. 2C), suggesting that gsk3alpha and gsk3beta may function differently during cardiogenesis, although they cause similar heart defects. We also noticed that the percentage of heart abnormalities was dependent on the concentration of the injected gsk3alpha- and gsk3beta-MO (Table 1). When 0.5 ng of gsk3alpha-MO was injected into 1-celled stage embryos, we found that 41.8% (n = 146) of embryos displayed a string-like-shape heart; whereas when 2 ng gsk3alpha-MO were injected, 88.2% (n = 212) of embryos appeared similar heart defect. Similarly, 2 ng gsk3beta-MO caused 30.2% (n = 126) of embryos to suffer a string-like-shape heart at 72 hpf; whereas 6 ng gsk3beta-MO caused 87.5% (n = 288) of embryos to have similar heart defect. These results indicated that the effect of gsk3-MO on embryogenesis was dosage-dependent and specific.
###end p 19
###begin p 20
###xml 29 39 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 43 52 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 0 61 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The morphological defects in <italic>gsk3&#945; </italic>and <italic>gsk3&#946; </italic>morphants</bold>
###xml 92 102 85 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 120 129 109 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 161 171 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 252 262 234 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 266 275 244 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
The morphological defects in gsk3alpha and gsk3beta morphants. Wild-type embryos (A, E, H), gsk3alpha (B, C, F, I), and gsk3beta (D, G, J) morphants. The 24 hpf gsk3alpha morphants have mild (C) to severe (B) defects in axis formation. At 72 hpf, both gsk3alpha and gsk3beta morphants displayed pericardial edema (F, G, I, J) and an unlooped, stretched heart (I, J).
###end p 20
###begin p 21
###xml 28 37 <span type="species:ncbi:7955">zebrafish</span>
Morphological phenotypes of zebrafish embryos derived from fertilized eggs injected with different materials
###end p 21
###begin p 22
###xml 60 70 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 111 120 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 231 237 224 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dsRed </italic>
Fertilized eggs were injected at the 1-cell stage, and then gsk3alpha morphants were observed at 36 to 48 hpf; gsk3beta morphants were observed the heart positioning at 24 to 36 hpf. Results are from three independent experiments. dsRed mRNA: served as a negative control.
###end p 22
###begin title 23
###xml 24 33 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 39 47 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
Heart defects caused by gsk3alpha- and gsk3beta-MO are induced differently
###end title 23
###begin p 24
###xml 90 100 90 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 103 111 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 197 206 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 225 234 214 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 304 313 289 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 330 331 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 349 357 330 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 406 414 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 444 453 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 478 486 449 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 531 532 499 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 777 786 <span type="species:ncbi:7955">zebrafish</span>
We investigated whether the MO-induced defects could be rescued by co-injecting synthetic gsk3alpha or gsk3beta-mRNA with its corresponding MOs, and vice versa. Results showed that co-injection of gsk3alpha-MO with synthetic gsk3alpha-mRNA could effectively rescue the defects caused by the injection of gsk3alpha-MO alone (Table 1). Similarly, the gsk3beta-MO-induced defects were rescued by injection of gsk3beta-mRNA. However, the synthetic gsk3alpha-mRNA did not rescue the gsk3beta-MO-induced phenotype, and vice versa (Table 1). This evidence clearly demonstrates that two isoforms of GSK3 are necessary for heart development, but the function of GSK3alpha and GSK3beta is not redundant, suggesting that GSK3alpha and GSK3beta play specific roles in cardiogenesis during zebrafish development.
###end p 24
###begin p 25
###xml 19 28 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 33 41 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 94 104 87 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cmlc2: gfp</italic>
###xml 234 236 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 307 315 300 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 431 433 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 530 532 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 621 623 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 624 626 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 639 644 632 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E, H</xref>
###xml 653 662 646 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 774 776 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3L</xref>
###xml 803 813 792 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 856 865 841 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 931 933 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 994 999 976 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3F, I</xref>
###xml 1049 1051 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3M</xref>
###xml 223 232 <span type="species:ncbi:7955">zebrafish</span>
###xml 915 924 <span type="species:ncbi:7955">zebrafish</span>
We injected either gsk3alpha- or gsk3beta-MO into embryos derived from the transgenic line Tg(cmlc2: gfp), in which the GFP is expressed specifically in heart, resulting in a good material to monitor cardiac development of zebrafish [29]. In the wild-type embryos, the heart precursor cells completed their in situ formation, elongated, and jogged to the left at 24 hpf; started looping at 30 hpf; and completed looping at 48 hpf [34]. However, we observed that heart development was retarded, failing to elongate at 24 hpf (Fig. 3B) and even ceasing at heart-cone stage without further morphogenesis to a heart tube at [30-36] hpf (Figs. 3E, H) in the gsk3alpha-MO-injected embryos. We observed defective hearts as stretched to a thin and string-like shape at 72 hpf (Fig. 3L). Nevertheless, unlike in gsk3alpha morphants, elongation of the heart tube in gsk3beta morphants at 24 hpf was as normal as in wild-type zebrafish (Fig. 3C), but heart looping was incomplete from 30 to 36 hpf (Figs. 3F, I), resulting in a stretched heart at 72 hpf (Fig. 3M).
###end p 25
###begin p 26
###xml 0 80 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The cardiac defects induced by the knockdown of zebrafish GSK3&#945; and GSK3&#946;</bold>
###xml 195 204 188 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 206 215 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 223 231 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 238 246 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 454 463 433 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 499 509 475 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 583 592 555 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 660 670 629 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 861 870 826 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 914 924 876 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 928 937 886 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 48 57 <span type="species:ncbi:7955">zebrafish</span>
The cardiac defects induced by the knockdown of zebrafish GSK3alpha and GSK3beta. Anti-sense morpholino oligonucleotide (MO), which was designed to specifically inhibit the translation of either gsk3alpha-(gsk3alpha-MO) or gsk3beta-mRNA (gsk3beta-MO), was injected into one-celled stage embryos and the heart morphology was observed at the stage as indicated. The elongation of heart tube was normally developed at 24 hpf in the wild-type (A) and in the gsk3beta morphants (C); whereas the heart of gsk3alpha morphant did not elongate to from a heart-tube (B). The wild-type (D) and gsk3beta morphant's heart (F) developed normally at 30 hpf, but the heart of gsk3alpha morphant was still retardant development at 30 hpf (E), and even ceased at heart-cone stage at 36 hpf (F). Compared to the wild-type (G), however, the heart positioning was abnormally in the gsk3beta morphant at 36 hpf (I, J). Eventually, both gsk3alpha and gsk3beta morphants displayed an unlooped and stretched heart (L, M). The heart morphology of embryos injected with the control MO was also observed at 72 hpf (N). a: atrium; v: ventricle.
###end p 26
###begin p 27
###xml 394 395 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3N</xref>
###xml 465 474 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 480 488 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
In addition, we have designed to an experiment for using a standard negative control morpolino (MO) injection: 5'-CCTCTTACCTCAGTTACAATTTATA-3' (Gene Tools, USA). This oligo has no target, no significant biological activity. After 2 and 6 ng of this control MO were injected, no any defects were observed at 24 hpf. The morphology and development of heart appeared normally (see Additional file 1 and Figure 3N). These results reveal that the defects induced by the gsk3alpha- and gsk3beta-MO are specific in this study.
###end p 27
###begin title 28
Effect of GSK3 on the number of cardiomyocytes is isoform-specific
###end title 28
###begin p 29
###xml 34 43 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 91 101 88 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 138 140 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 290 295 279 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cmlc2</italic>
###xml 380 385 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cmlc2</italic>
###xml 424 434 413 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 492 497 477 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B, E</xref>
###xml 568 578 553 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 650 660 631 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 760 769 737 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 796 802 770 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cmlc2 </italic>
###xml 817 822 791 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C, F</xref>
###xml 883 892 857 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
Compared to that of wild-type and gsk3beta morphants, the GFP signals in cardiomyocytes of gsk3alpha morphants were greatly reduced (Fig. 3B). To investigate whether the reduced GSK3alpha level affects the cardiomyocyte number, we used a cardiomyocyte marker, cardiac myosin light chain 2 (cmlc2), to detect cells at heart-field and heart-cone stages. We found that the number of cmlc2-positive cells was greatly reduced in gsk3alpha morphants at both heart-field and heart-cone stages (Fig. 4B, E), indicating that the cardiomyocyte number was greatly reduced in the gsk3alpha morphants. These results suggest that the retarded heart development in gsk3alpha morphants is due to the decreased number of cardiomyocytes during early cardiogenesis. In contrast, gsk3beta morphants displayed normal cmlc2 staining (Fig. 4C, F), indicating that cardiomyocyte number remains unchanged in gsk3beta morphants. These results also clearly demonstrate that GSK3alpha and GSK3beta play distinct roles during cardiogenesis.
###end p 29
###begin p 30
###xml 21 31 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 0 91 0 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The heart defects in <italic>gsk3&#945; </italic>morphants weredue to a reduced cardiomyocyte population size</bold>
###xml 152 160 148 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 215 223 211 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 251 257 247 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cmlc2 </italic>
###xml 288 297 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 386 396 378 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 474 483 462 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 627 632 612 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3a</italic>
###xml 730 739 715 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 811 815 793 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cmlc</italic>
###xml 888 898 870 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
The heart defects in gsk3alpha morphants weredue to a reduced cardiomyocyte population size. Dorsal (A-I) and lateral (J-O) views of embryos stained by in situ hybridization (A-F) and TUNEL assay (G-L). Whole mount in situ hybridization staining with cmlc2 at 18 and 23 hpf received that gsk3alpha-MO causes a repressive influence on cardiomyocyte formation (B, E). The heart defect in gsk3alpha morphants was due to the reduction of cardiomyocyte population size. However, gsk3beta morphants display normal cardiomyocyte formation (C, F) compared to wild-type embryos (A, D). TUNEL labeling was evident throughout the head of gsk3a-MO-injected embryos (H), especially in the head, but was limited in the head of controls (G) and gsk3beta morphants (I). Compared to embryos derived from the transgenic line, Tg(cmlc2:EGFP), which has heart-specific GFP (K), we observed that the heart of gsk3alpha morphant did not elongate to form a heart-tube and the GFP signal was very faint at 24 hpf (N). Panels L and O are the merged images from J and K, and M and N, respectively. The apoptotic signals were co-localized with the heart-specific GFP signal, indicating that the reduced cardiomyocyte numbers was due to apoptosis in heart (O). h: heart.
###end p 30
###begin title 31
###xml 32 42 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
Apoptosis occurs in the head of gsk3alpha knockdown embryos
###end title 31
###begin p 32
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3</italic>
###xml 67 69 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 70 72 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 103 105 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 163 173 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 392 394 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4G</xref>
###xml 409 419 401 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 523 525 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4H</xref>
###xml 575 584 563 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 612 617 597 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3a</italic>
###xml 675 677 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4N</xref>
###xml 842 844 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4O</xref>
###xml 884 894 869 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
The pronounced degeneration in the head of gsk3alpha morphants at [18-30] hpf were also observed (Fig. 2C). To confirm whether the reduced cardiomyocyte number in gsk3alpha morphants was due to apoptosis, the embryos were analyzed by Terminal deoxynucleotidyl Transferase Biotin-dUTP Nick End Labeling (TUNEL) assay after MO injection. In wild-type embryos at 20 hpf, apoptosis was low (Fig. 4G). However, in gsk3alpha morphants at the same stage, apoptosis was pronounced throughout the axis, especially in the head (Fig. 4H) but was limited in the head of controls (G) and gsk3beta morphants (I). Moreover, In gsk3a-morphants, the GFP signal was very faint at 24 hpf (Fig. 4N). The apoptotic signals were co-localized with the heart-specific GFP signal, indicating that the reduced cardiomyocyte numbers was due to apoptosis in heart (Fig. 4O). Taken together, the heart defects in gsk3alpha morphants was due to the reduced number of cardiomyocytes, which results from apoptosis in the head.
###end p 32
###begin title 33
GSK3beta, but not GSK3alpha, is involved in the cardiac positioning
###end title 33
###begin p 34
###xml 22 30 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 159 168 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 298 306 289 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 327 333 318 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cmlc2 </italic>
###xml 455 457 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 496 505 487 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 521 525 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B&#8211;D</xref>
###xml 630 639 618 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 661 662 646 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 723 732 708 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 810 818 792 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 851 860 830 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 1300 1305 1273 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vmhc </italic>
###xml 1336 1341 1309 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">amhc </italic>
###xml 1370 1379 1343 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 1395 1400 1365 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E, G</xref>
###xml 1405 1410 1375 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5F, H</xref>
###xml 1597 1607 1564 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 1704 1706 1667 1669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1707 1709 1670 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
Although the heart of gsk3beta-MO-injected embryos eventually becomes a string-like shape, we found that the cardiomyocyte development was not affected in the gsk3beta morphants during early cardiac development, suggesting that GSK3beta may play a unique role in cardiac morphogenesis. Whole-mount in situ hybridization of the cmlc2 probe at 36 hpf, outlining cardiac looping, was marked by a rightward bending in the ventricle in wild-type embryos (Fig. 5A). However, no looping was observed in gsk3beta morphants (Fig. 5B-D). Upon detailed analysis of the early (jogging) and late (looping) stages of cardiac positioning in the gsk3beta morphant heart (Table 2), we found that heart positioning was severely disrupted in gsk3beta morphants and that the extent of the defect was proportional to the amount of gsk3beta-MO we injected. The majority of gsk3beta morphant hearts failed to jog (69.9%; 65/93). Moreover, this defect was frequently accompanied by no looping (45.3%) or L-looping (14.4%) of the heart tube, compared to wild-type, which has correct left-jogging (93.1%; 67/72) and D-looping (92.4%; 122/132). These results indicate that knockdown of GSK3beta resulted in a severe disruption of jogging and looping of cardiac positioning. However, we found that the ventricle-specific marker vmhc and the atrium-specific marker amhc were normally transcribed in gsk3beta morphants (Fig. 5E, G vs. 5F, H), suggesting that GSK3beta might not affect the chamber-specific pattern of gene expression, although normal heart looping was not completed. We also noted that the heart positioning in gsk3alpha morphants was delayed but that correct jogging (left-jog) and looping (D-loop) were observed at [36-48] hpf, indicating that GSK3alpha was not involved in heart positioning.
###end p 34
###begin p 35
###xml 23 31 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 0 85 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cardiac positioning is <italic>gsk3&#946;</italic>-dependent, but the chamber-specific patterning is not</bold>
###xml 155 163 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk&#946; </italic>
###xml 196 204 190 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 223 229 217 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cmlc2 </italic>
###xml 287 296 281 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 331 336 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vmhc </italic>
###xml 344 349 335 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">amhc </italic>
###xml 372 381 363 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
Cardiac positioning is gsk3beta-dependent, but the chamber-specific patterning is not. A-C, E-H) ventral view, (D) dorsal view of wild-type (A, E, G), and gskbeta morphants (B-D, F, H) at 36 hpf. in situ hybridization with cmlc2 staining revealed that randomized looping was observed in gsk3beta morphants (B-D). The expression of vmhc (F) and amhc (H) appeared normal in gsk3beta morphants.
###end p 35
###begin p 36
Knockdown GSK3beta levels that disrupt normal cardiac jogging and looping
###end p 36
###begin p 37
###xml 0 10 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
gsk3alpha morphants were analyzed for heart positioning at 36 to 48 hpf; gsk3beta morphants were analyzed for heart positioning at 24 to 36 hpf.
###end p 37
###begin title 38
###xml 18 23 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 27 35 24 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lefty-1 </italic>
GSK3beta mediates bmp4 and lefty-1 in cardiac positioning and is required for left-right patterning
###end title 38
###begin p 39
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 295 300 295 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A, B</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6G</xref>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 457 466 457 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 513 518 510 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D, E</xref>
###xml 638 643 635 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6H, I</xref>
###xml 683 691 680 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lefty-1 </italic>
###xml 692 694 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 759 768 756 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 784 789 778 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C, F</xref>
###xml 826 831 817 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 835 843 826 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lefty-1 </italic>
###xml 129 138 <span type="species:ncbi:7955">zebrafish</span>
Cardiac bmp4 is an integral component involved in the asymmetric signaling pathway and interprets left-right information for the zebrafish embryo heart [35]. The bmp4 transcripts became markedly asymmetric, with far more on the left side than on the right side of the heart ring at 20 hpf (Fig. 6A, B), just before jogging. This left-predominant asymmetry persists through the stages of jogging (25 hpf, Fig. 6G). However, the pattern of bmp4 expression in gsk3beta morphants was symmetrical before jogging (Fig. 6D, E) and ectopic around the heart-tube stage at 25 hpf, thereby disrupting the pattern of left-predominant asymmetry (Fig. 6H, I). Moreover, another asymmetric marker, lefty-1 [36], lost its expression domain in the left side of the midline in gsk3beta morphants (Fig. 6C, F). We propose that GSK3beta mediates bmp4 and lefty-1 in cardiac positioning.
###end p 39
###begin p 40
###xml 32 41 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 0 50 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Heart asymmetry was affected in <italic>gsk3&#946; </italic>morphants</bold>
###xml 62 67 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 182 187 179 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 253 262 250 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 291 296 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 337 346 331 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 390 395 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 465 473 456 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lefty-1 </italic>
###xml 503 512 494 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
Heart asymmetry was affected in gsk3beta morphants. Normally, bmp4 transcripts accumulate predominantly on the left side of the heart tube at 20 hpf (A, B), and the left-predominant bmp4 asymmetry persists through the stages of jogging (G). However, in gsk3beta morphants, the expression of bmp4 becomes symmetrical at 20 hpf (B, D). In gsk3beta morphants, in which the heart fails to jog, bmp4 is more evenly distributed in the heart region (H, I). The left-sided lefty-1 domain was greatly reduced in gsk3beta morphant hearts at 16 hpf (F). All are dorsal views. B, E are higher magnifications of A, D, respectively. Lines mark the midline. L, embryo left.
###end p 40
###begin title 41
GSK3beta modulates valve formation and heart position through Wnt/beta-catenin signaling
###end title 41
###begin p 42
###xml 54 62 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 135 140 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 144 153 141 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versican </italic>
###xml 167 175 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 290 294 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A&#8211;D</xref>
###xml 524 536 515 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cmlc2:Hc-RFP</italic>
###xml 778 780 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E</xref>
###xml 819 827 810 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 857 859 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7F</xref>
###xml 75 84 <span type="species:ncbi:7955">zebrafish</span>
###xml 506 515 <span type="species:ncbi:7955">zebrafish</span>
Many morphological defects of heart were found in the gsk3beta-MO-injected zebrafish embryos. Moreover, when we used the valve markers bmp4 and versican to detect the gsk3beta-MO-injected embryos at 60-72 hpf, we found that these valve markers were markedly up-regulated in the heart (Fig. 7A-D), suggesting that GSK3beta might also be involved in the formation of cardiac valves. Thus, we used a two-photon fluorescence image to directly observe the valve formation of embryos derived from the transgenic zebrafish line Tg(cmlc2:Hc-RFP; 28). The yellow color shown in our nonlinear microscopy image (valves and red blood cells) is corresponding to the image modality taken by the Third-Harmonic-Generation Microscopy. Valves were normally formed in the wild-type embryos (Fig. 7E), but valves of embryos injected with gsk3beta-MO were totally absent (Fig. 7F).
###end p 42
###begin p 43
###xml 17 19 17 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(apc</italic>
###xml 109 112 109 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mcr</italic>
###xml 109 112 109 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>mcr</italic></sup>
###xml 112 113 112 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">)</italic>
###xml 133 138 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">axin1</italic>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2A&#8211;D</xref>
###xml 419 427 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 488 491 485 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apc</italic>
###xml 491 495 488 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mcr </italic>
###xml 491 495 488 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>mcr </italic></sup>
###xml 507 513 504 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">axin1 </italic>
###xml 83 92 <span type="species:ncbi:7955">zebrafish</span>
Hurlstone et al [37] reported that cardiac valve formation is severely affected in zebrafish APC mutants (apcmcr). Furthermore, when axin1, another key component in the Wnt pathway, is knocked down, either a reduction or absence of heart positioning of the heart tube was frequently observed (see Additional file 2A-D). GSK3 is known to be important in the canonical Wnt pathway, and the defective valves and hearts in gsk3beta-MO-injected embryos were identical to those observed in the apcmcr mutants and axin1 morphants, suggesting that GSK3beta modulates cardiac development through Wnt/beta-catenin signaling.
###end p 43
###begin p 44
###xml 0 52 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GSK3&#946; modulates zebrafish cardiac valve formation</bold>
###xml 66 74 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 93 98 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 102 111 99 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versican </italic>
###xml 175 184 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 208 217 202 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versican </italic>
###xml 228 233 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 279 288 273 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 302 315 293 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cmlc2: Hc-RFP</italic>
###xml 344 352 335 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 372 380 360 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 646 655 634 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 19 28 <span type="species:ncbi:7955">zebrafish</span>
###xml 433 442 <span type="species:ncbi:7955">zebrafish</span>
GSK3beta modulates zebrafish cardiac valve formation. Whole-mount in situ hybridization with bmp4 and versican staining reveals that cardiac valve development was affected in gsk3beta morphants. At 60-72 hpf,versican (A, B) and bmp4 (C, D) expression was greatly up-regulated in gsk3beta morphants. Tg(cmlc2: Hc-RFP) embryos were injected with gsk3beta-MO and observed by in vivo two-photon fluorescence imaging of a live transgenic zebrafish heart at 100 hpf. The endocardial cells and blood are labeled yellow; the Hc-GFP-positive myocardial cells are labeled red. Valves are clearly observed in wild-type embryos (E; white arrows), but not in gsk3beta morphants (F). b, blood cells; V, ventricle; A, atrium.
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 134 135 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 294 296 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 448 457 428 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 458 459 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 544 552 524 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 259 267 <span type="species:ncbi:9606">patients</span>
###xml 671 680 <span type="species:ncbi:7955">zebrafish</span>
GSK3beta knockout mice display an embryonic lethal phenotype, indicating that GSK3alpha does not compensate for the loss of GSK3beta [9]. Furthermore, the activity of GSK3alpha, but not GSK3beta, is required for the production of amyloid-beta in the brain of patients with Alzheimer's disease [38]. All these findings indicate that there may be isoform-specific functions of GSK3, although they exhibit similar biochemical and substrate properties in vitro [7]. However, to clearly delineate the biological functions of these two GSK3 isoforms in vivo is difficult and little reported. In this report, we study the roles of GSK3alpha and GSK3beta in the cardiogenesis of zebrafish using a loss-of-function approach. The loss of either GSK3alpha or GSK3beta results in abnormal development of heart. Yet, the role that GSK3 plays in cardiogenesis is in an isoform-specific manner. GSK3alpha plays a role in the survival of cardiomyocytes, whereas GSK3beta plays a role in heart left-right biased positioning, modulated through the Wnt/beta-catenin signaling pathway.
###end p 46
###begin title 47
###xml 51 60 <span type="species:ncbi:7955">zebrafish</span>
GSK3alpha and GSK3beta play different roles during zebrafish embryogenesis
###end title 47
###begin p 48
###xml 23 33 23 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 37 46 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 166 175 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 183 191 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 228 230 214 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 231 240 217 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cmlc2:GFP</italic>
###xml 390 400 376 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 487 496 469 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 572 580 550 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 746 753 721 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3&#945; </italic>
###xml 760 766 731 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3&#946; </italic>
###xml 213 222 <span type="species:ncbi:7955">zebrafish</span>
###xml 901 910 <span type="species:ncbi:7955">zebrafish</span>
Although, knockdown of gsk3alpha and gsk3beta causes similar defective phenotypes, such as an unlooped and stretched heart, pericardial edema, blood pooling. We used gsk3alpha-MO and gsk3beta-MO in the transgenic zebrafish line Tg(cmlc2:GFP), in which GFP is expressed in the myocardium specifically, to modulate and observe, in real-time, the different defective phenotypes. The hearts of gsk3alpha morphants failed to elongate at 24 hpf. We prove that the heart defects induced by the gsk3alpha-MO are due to a decreased number of cardiomyocytes. On the other hand, the gsk3beta-MO-injected embryos develop normally before the onset of cardiac jogging. Defective heart positioning is observed after 26 hpf. Rescue experiments revealed that GSK 3alpha and GSK3beta do not function redundantly. Taken together, we conclude that each isoform of GSK3 plays its own distinct role during cardiogenesis of zebrafish.
###end p 48
###begin title 49
GSK3alpha, but not GSK3beta, is involved in apoptosis during early embryogenesis
###end title 49
###begin p 50
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 365 367 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 368 370 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 473 480 467 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3&#945; </italic>
###xml 487 493 477 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3&#946; </italic>
###xml 645 655 632 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 725 734 708 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 895 904 868 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 912 921 881 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 976 983 942 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3&#945; </italic>
###xml 990 996 952 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3&#946; </italic>
GSK3 plays an important role in the regulation of apoptosis/cell survival through the activation of caspase3 [39,41,42]. These findings support a role of GSK3beta in controlling apoptosis. Many studies reporting the affect of GSK3beta on apoptosis have been confirmed by using GSK3 inhibitors, including lithium, the first known inhibitor, and many synthetic ones [43-45]. However, these inhibitors have many effects on cells and are not isoform-specific. Thus, whether GSK3alpha and GSK3beta function redundantly or distinctly on cell survival is still ambiguous. In our study, extensive apoptosis is observed throughout the head region in the gsk3alpha morphants. On the other hand, only slight apoptosis is noticed in the gsk3beta morphants, suggesting that GSK3alpha, but not GSK3beta, is greatly involved in apoptosis during early embryogenesis. Moreover, embryos that are co-injected with gsk3alpha-MO and gsk3beta mRNA do not show reduced apoptosis, suggesting that GSK3alpha and GSK3beta do not function redundantly in cell survival.
###end p 50
###begin title 51
GSK3alpha-mediated apoptosis may not be implicated in Wnt signaling
###end title 51
###begin p 52
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 230 232 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 310 312 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 313 315 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 332 335 329 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apc</italic>
###xml 335 339 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mcr </italic>
###xml 335 339 332 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>mcr </italic></sup>
###xml 458 460 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 468 471 465 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apc</italic>
###xml 471 475 468 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mcr </italic>
###xml 471 475 468 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>mcr </italic></sup>
###xml 479 485 476 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">axin1 </italic>
###xml 493 499 490 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(mbl) </italic>
###xml 552 561 549 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 627 630 621 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apc</italic>
###xml 630 634 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mcr </italic>
###xml 630 634 624 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>mcr </italic></sup>
###xml 638 642 632 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mbl </italic>
###xml 712 722 706 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 750 755 740 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">axin1</italic>
###xml 784 788 774 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mbl </italic>
###xml 906 915 896 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 965 975 952 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 1006 1007 989 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1143 1149 1122 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">axin1 </italic>
###xml 321 330 <span type="species:ncbi:7955">zebrafish</span>
###xml 798 807 <span type="species:ncbi:7955">zebrafish</span>
The Wnt signaling are involved in cell proliferation and in apoptosis [46-49]. On the other hand, PKB/Akt, a major regulator of GSK3, also triggers a network that regulates cell cycle progression through inactivation of GSK3beta [50]. It has been shown that PKB/Akt promotes cell survival in cardiac myocytes [51,52]. In zebrafish, apcmcr mutant's hearts are morphologically normal during early cardiogenesis, but they fail to undergo looping morphogenesis [37]. Both apcmcr and axin1 mutants (mbl) display cardiac defects that are similar to those of gsk3beta morphants. However, no information is provided about apoptosis in apcmcr and mbl mutants. In this report, we find that apoptosis occurs in the head of gsk3alpha morphants. In addition, the axin1-MO-injected embryos and the mbl mutant of zebrafish have defects of looping morphogenesis in the heart, which are similar to defects occurring in the gsk3beta morphants but are unlike defects occurring in the gsk3alpha morphants (see Additional file 2). Therefore, we know that GSK3alpha may not mediate apoptosis implicated in Wnt signaling because apoptotic signals do not increase in axin1 morphants (data not shown). It is worth studying which pathway is implicated in GSK3alpha-mediated apoptosis.
###end p 52
###begin title 53
###xml 0 9 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 19 24 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
gsk3beta regulates bmp4 during cardiac development through Wnt/beta-catenin signaling
###end title 53
###begin p 54
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apc</italic>
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mcr </italic>
###xml 21 25 21 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>mcr </italic></sup>
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mbl </italic>
###xml 171 173 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 226 235 223 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 251 252 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 283 286 277 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apc</italic>
###xml 286 290 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mcr </italic>
###xml 286 290 280 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>mcr </italic></sup>
###xml 321 326 315 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 378 387 372 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versican </italic>
###xml 438 441 432 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apc</italic>
###xml 441 445 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mcr </italic>
###xml 441 445 435 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>mcr </italic></sup>
###xml 463 472 457 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 488 492 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A&#8211;D</xref>
###xml 522 527 513 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 595 600 586 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 626 635 617 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 658 663 646 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 727 729 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 730 732 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 804 813 <span type="species:ncbi:7955">zebrafish</span>
The phenotypes of apcmcr and mbl mutants are similar to our results in that inhibition of GSK3beta also causes unlooping heart tube, pericardial edema, and blood pooling [37]. In addition, valve development is totally lost in gsk3beta morphants (Fig. 7), which is similar to that of apcmcr mutants. Ectopic expression of bmp4 in the heart at 24-72 hpf and ectopic expression of versican in the valve at 60-72 hpf are also observed in the apcmcr mutant and in the gsk3beta morphant (Figs. 7A-D). Moreover, the retention of bmp4 symmetry is associated with disordered jogging, and we observe that bmp4 retention occurred in the gsk3beta morphant. In addition, bmp4 is downstream of Wnt/beta-catenin signaling in several systems [53,54]. Therefore, it is reasonable to conclude that GSK3beta might regulate zebrafish cardiac development by means of the canonical Wnt/beta-catenin signaling pathway.
###end p 54
###begin title 55
GSK3beta may be involved in the regulation of T-box genes during cardiogenesis
###end title 55
###begin p 56
###xml 36 45 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 106 119 103 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">heartstrings </italic>
###xml 153 158 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tbx5 </italic>
###xml 159 161 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 285 290 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tbx5 </italic>
###xml 291 293 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 318 323 315 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tbx5 </italic>
###xml 416 418 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 419 421 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 458 467 455 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 616 617 610 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 619 620 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 769 770 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 874 876 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 164 172 <span type="species:ncbi:9606">Patients</span>
###xml 228 233 <span type="species:ncbi:9606">human</span>
###xml 776 781 <span type="species:ncbi:9031">chick</span>
Our study reveals that knockdown of gsk3beta causes a string-like heart. This phenotype is similar to the heartstrings mutant, caused by mutation of the tbx5 [55]. Patients with Holt-Oram syndrome, one of the autosomal dominant human "heart-hand" disorders, are caused by mutations of tbx5 [56]. Both loss and gain of tbx5 functions result in an absence of heart looping and an alteration in cardiac-specific genes [57,58]. In our study, we demonstrate that gsk3beta morphants appear to have multiple heart defects, such as a non-looping or reversed looping heart, slower heart rate, and no blood circulation (Figs. 3, 4). In addition, after we probe with fin markers, we prove that the pectoral fin of the GSK3beta morphant fails to differentiate (see Additional file 3). In chick, Tbx5 and Tbx4 trigger limb initiation through activation of the Wnt/Fgf signaling cascade [59]. Therefore, we propose that GSK3beta and Tbx5 might be involved in the same regulatory mechanism during cardiogenesis.
###end p 56
###begin title 57
###xml 86 93 86 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish is an alternative, promising model animal to study GSK3-specific inhibitors in vivo
###end title 57
###begin p 58
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 460 468 460 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 590 598 590 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 876 884 869 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 551 560 <span type="species:ncbi:7955">zebrafish</span>
###xml 756 765 <span type="species:ncbi:7955">zebrafish</span>
GSK3 is a target of prominent drugs for treating many diseases, including Alzheimer's disease and diabetes mellitus. Substrate-competitive inhibitors, which compete for the substrate binding site of the kinase, are more likely to be highly specific inhibitors. Several ATP-competitive inhibitors of GSK3 have also been defined [17,18]. However, the development of new drug not only requires the identification of the target, but also requires validation in an in vivo system. Recently, Atilla-Gokcumen et al., [60] performed phenotypic experiments in zebrafish embryo which is served as an in vivo experiment to analyse the functions of novel GSK3 inhibitor, organometallic reagent (R)-7. In this study, we clearly distinguish the morphological defects in zebrafish GSK3alpha- and GSK3beta-knockdown embryos. Therefore, these findings will surely provide new criteria for the in vivo validation of potential isoform-specific inhibitors of GSK3.
###end p 58
###begin title 59
Different biological function of GSK3 isoform in species
###end title 59
###begin p 60
###xml 157 165 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 226 229 216 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apc</italic>
###xml 229 233 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mcr </italic>
###xml 229 233 219 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>mcr </italic></sup>
###xml 245 251 235 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">axin1 </italic>
###xml 543 544 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 809 817 780 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 842 851 813 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 896 913 864 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus gsk3&#946; </italic>
###xml 976 978 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 979 981 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 87 96 <span type="species:ncbi:7955">zebrafish</span>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
###xml 792 801 <span type="species:ncbi:7955">zebrafish</span>
###xml 809 816 <span type="species:ncbi:8355">Xenopus</span>
###xml 832 841 <span type="species:ncbi:7955">zebrafish</span>
###xml 896 903 <span type="species:ncbi:8355">Xenopus</span>
In this report, we have defined that GSK3alpha and GSK3beta play distinct roles during zebrafish cardiogenesis. Moreover, the defective valves and hearts in gsk3beta-MO-injected embryos were identical to those observed in the apcmcr mutants and axin1 morphants, suggesting that GSK3beta modulates cardiac development through Wnt/beta-catenin signaling. In addition, GSK3 is a critical regulator of Wnt signaling mechanism, several recent studies have shown that the components of the Wnt signaling play an important role in heart development [3]. However, heart defects are not reported in the GSK3beta-knockout mice. One of reasons is that mice GSK3alpha might function redundantly to GSK3beta during the heart development of mice. We also notice that the expression profiles of GSK3beta in zebrafish and in Xenopus are different: zebrafish gsk3beta is weakly detected until 50-60% epiboly, but Xenopus gsk3beta is expressed strongly and constantly throughout embryogenesis [61,62]. Taken together, although GSK3 isoforms share highly conserved in their functional domain, the biological functions of GSK3 isoforms in different species are not identical.
###end p 60
###begin title 61
Conclusion
###end title 61
###begin p 62
###xml 352 361 335 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 405 411 385 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">axin1 </italic>
###xml 415 418 395 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apc</italic>
###xml 418 421 398 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mcr</italic>
###xml 418 421 398 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>mcr</italic></sup>
###xml 560 570 534 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945; </italic>
###xml 608 617 578 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 73 82 <span type="species:ncbi:7955">zebrafish</span>
###xml 278 287 <span type="species:ncbi:7955">zebrafish</span>
###xml 787 796 <span type="species:ncbi:7955">zebrafish</span>
Our data indicate that GSK3alpha and GSK3beta play distinct roles during zebrafish embryogenesis. GSK3alpha, but not GSK3beta, is necessary in cardiomyocyte survival; GSK3beta plays an important role in regulating left-right biased heart positioning during the cardiogenesis in zebrafish. We also demonstrate that the cardiac valve defects observed in gsk3beta morphants were similar to those observed in axin1 and apcmcrmutants, suggesting that GSK3beta modulates valve formation and heart position through Wnt/beta-catenin signaling. Finally, the defects of gsk3alpha morphant embryos cannot be rescued by gsk3beta mRNA, and vice versa, demonstrating that GSK3alpha and GSK3beta are not functionally equivalent. Thus, we conclude that GSK3alpha and GSK3beta play distinct roles during zebrafish cardiogenesis.
###end p 62
###begin title 63
Methods
###end title 63
###begin title 64
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish maintenance and observation
###end title 64
###begin p 65
###xml 45 57 45 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cmlc2:Hc-RFP</italic>
###xml 66 75 66 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cmlc2:GFP</italic>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 4 13 <span type="species:ncbi:7955">zebrafish</span>
The zebrafish AB strain, transgenic lines Tg(cmlc2:Hc-RFP) and Tg(cmlc2:GFP) were raised and staged as previously described (28-30). The heart formation were observed under a fluorescent stereomicroscope MZ FLIII (Leica) and two-photon fluorescence microscope and Third-Harmonic-Generation Microscopy [28].
###end p 65
###begin title 66
###xml 28 37 <span type="species:ncbi:7955">zebrafish</span>
Knockdown microinjection of zebrafish embryos
###end title 66
###begin p 67
###xml 89 98 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;</italic>
###xml 130 138 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 170 175 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">axin1</italic>
The following morpholino antisense oligonucleotides (MOs) were obtained from Gene Tools: gsk3alpha-MO, CCGCTGCCGCTCATTTCGGGTTGCA; gsk3beta-MO, GTTCTGGGCCGACCGGACATTTTTC; axin1-MO, GCTAATGCGGTCATATCTCCTCTGC; standard negative control-MO, CCTCTTACCTCAGTTACAATTTATA. All MOs were prepared at a stock concentration of 1 mM and diluted to the desired concentration for microinjection into each embryo.
###end p 67
###begin title 68
Western blot
###end title 68
###begin p 69
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
The embryos were dechorionated and deyolked with two extra washing steps as described in Link et al. [31]. Deyolked samples were dissolved in 2 mul of 2 x sodium dodecyl sulfate (SDS) sample buffer per embryo and incubated for 5 min at 95degreesC. After full-speed centrifugation for 1 min in a microcentrifuge to remove insoluble particles, samples were loaded on a 12% SDS gel (seven embryos per lane). Antibodies used were anti-GSK3 (Santa Cruz, SC-7291, 1:750) and anti-alpha-tubulin (Sigma-Aldrich, T9026, 1:750).
###end p 69
###begin title 70
###xml 12 20 12 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
Whole-mount in situ hybridization
###end title 70
###begin p 71
###xml 12 20 12 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
Whole-mount in situ hybridization techniques have been described previously [32]. The probes were digoxigenin-labeled, after which we cloned their partial DNA fragments.
###end p 71
###begin title 72
mRNA preparation for the rescue experiment
###end title 72
###begin p 73
###xml 16 35 16 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#945;, gsk3&#946;</italic>
###xml 41 45 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RFP </italic>
Capped mRNAs of gsk3alpha, gsk3beta, and RFP were synthesized according to the protocol of the manufacturer (Epicentre). The resultant mRNAs were diluted to 44 ng/mul with distilled water. Approximately 2.3 nl was injected into one-cell stage embryos.
###end p 73
###begin title 74
Detection of apoptotic cell death
###end title 74
###begin p 75
###xml 133 135 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
The apoptosis assay was performed using The DeadEndtrade mark Colorimetric TUNEL System (Promega) and has been described previously [33].
###end p 75
###begin title 76
Authors' contributions
###end title 76
###begin p 77
HCL designed and performed all the experiments, analysis the data, and prepared the manuscript. JNT and WCC carried out the Western blot analysis; KYL, PYL and WYT took care of fish handling including morpholino injections. CCC and CKS performed the two-photon fluorescence microscope imaging; HJT was a P.I. of this project. All authors read and approved the final manuscript.
###end p 77
###begin title 78
Supplementary Material
###end title 78
###begin title 79
Additional file 1
###end title 79
###begin p 80
###xml 28 37 <span type="species:ncbi:7955">zebrafish</span>
Morphological phenotypes of zebrafish embryos derived from fertilized eggs injected with standard control morpholino. The standard negative control-MO has no target, no significant biological activity, and are commonly used in many studies (Hultman et al., 2007; Besser et al., 2007; Nixon et al., 2005). After 2 and 6 ng of this control MO were injected, no any defects were observed at 24 hpf. The morphology and development of heart appeared normally.
###end p 80
###begin p 81
Click here for file
###end p 81
###begin title 82
Additional file 2
###end title 82
###begin p 83
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">axin1 </italic>
###xml 45 54 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 77 85 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946;</italic>
###xml 256 262 250 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">axin1 </italic>
Similar cardiac defects in the axin1 and the gsk3beta morphants. Axin1-MO or gsk3beta-MO were microinjcetd to And observed under dissecting microscope by bright filed (A, C) or fluorescence (B, D). Incomplete looping of the heart tube was also observed in axin1 mutant heart.
###end p 83
###begin p 84
Click here for file
###end p 84
###begin title 85
Additional file 3
###end title 85
###begin p 86
###xml 39 48 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 112 121 109 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 217 221 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">shh </italic>
###xml 225 230 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dlx2 </italic>
###xml 293 302 287 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 351 355 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">shh </italic>
###xml 363 368 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dlx2 </italic>
###xml 424 433 415 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsk3&#946; </italic>
###xml 448 452 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">shh </italic>
###xml 456 461 444 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dlx2 </italic>
Arrested pectoral fin bud induction in gsk3beta morphants. At 72 hpf, wild-type pectoral fins elongate (A), but gsk3beta morphants have still not developed fin buds (arrows; D). Whole mount in situ hybridization with shh and dlx2 staining reveal that the developed of fin bud were affected in gsk3beta morphants. At 36 hpf, wild-type embryos continue shh (B) and dlx2 (C) expression in the developing bud mesenchyme, but in gsk3beta morphants, the shh and dlx2 expression is greatly decreased.
###end p 86
###begin p 87
Click here for file
###end p 87
###begin title 88
Acknowledgements
###end title 88
###begin p 89
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bmp4 </italic>
###xml 71 80 71 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versican </italic>
###xml 143 151 143 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lefty-1 </italic>
We are grateful to Dr. Anna-Pavlina Haramis for providing the bmp4 and versican probes, to Drs. Christine and Bernard Thisse for providing the lefty-1 probe. This work was partially supported by the National Science Council, Republic of China, under grand no. NCS-95-2313-B-002-067-My2 (HJT), and partially supported by National Health Research Institute, grand no NHRI-EX96-9201EI (CKS).
###end p 89
###begin article-title 90
Molecular cloning and expression of glycogen synthase kinase-3/factor A
###end article-title 90
###begin article-title 91
Glycogen synthase kinase-3: functions in oncogenesis and development
###end article-title 91
###begin article-title 92
Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development
###end article-title 92
###begin article-title 93
Re-evaluating the role of Frat in Wnt-signal transduction
###end article-title 93
###begin article-title 94
cDNA cloning and properties of glycogen synthase kinase-3
###end article-title 94
###begin article-title 95
Judging a protein by more than its name: GSK-3
###end article-title 95
###begin article-title 96
Glycogen synthase kinase-3: properties, functions, and regulation
###end article-title 96
###begin article-title 97
###xml 67 76 <span type="species:ncbi:7955">zebrafish</span>
Differential expression of glycogen synthase kinase 3 genes during zebrafish embryogenesis
###end article-title 97
###begin article-title 98
Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation
###end article-title 98
###begin article-title 99
Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival
###end article-title 99
###begin article-title 100
###xml 53 59 <span type="species:ncbi:9986">rabbit</span>
The alpha-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro
###end article-title 100
###begin article-title 101
Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling
###end article-title 101
###begin article-title 102
Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes
###end article-title 102
###begin article-title 103
Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes
###end article-title 103
###begin article-title 104
###xml 44 49 <span type="species:ncbi:9606">human</span>
Regulation of glycogen synthase kinase-3 in human skeletal muscle: effects of food intake and bicycle exercise
###end article-title 104
###begin article-title 105
###xml 93 96 <span type="species:ncbi:10116">rat</span>
Insulin and exercise decrease glycogen synthase kinase-3 activity by different mechanisms in rat skeletal muscle
###end article-title 105
###begin article-title 106
GSK3 inhibitors: development and therapeutic potential
###end article-title 106
###begin article-title 107
Pharmacological inhibitors of glycogen synthase kinase 3
###end article-title 107
###begin article-title 108
Glycogen synthase kinase 3: a drug target for CNS therapies
###end article-title 108
###begin article-title 109
Activated glycogen synthase-3beta suppresses cardiac hypertrophy in vivo
###end article-title 109
###begin article-title 110
Fas receptor signaling inhibits glycogen synthase kinase 3s and induces cardiac hypertrophy following pressure overload
###end article-title 110
###begin article-title 111
Glycogen Synthase Kinase-3s Is a Negative Regulator of Cardiomyocyte Hypertrophy
###end article-title 111
###begin article-title 112
Glycogen synthase kinase-3beta regulates growth, calcium homeostasis, and diastolic function in the heart
###end article-title 112
###begin article-title 113
Heart induction by Wnt antagonists depends on the homeodomain transcription factor Hex
###end article-title 113
###begin article-title 114
The epidemiology of cardiovascular defects, part 2: a study based on data from three large registries of congenital malformations
###end article-title 114
###begin article-title 115
Lithium and the newborn heart
###end article-title 115
###begin article-title 116
Related Maternal drugs and congenital heart disease
###end article-title 116
###begin article-title 117
Biomolecular imaging based on far-red fluorescent protein with a high two-photon excitation action cross section
###end article-title 117
###begin article-title 118
###xml 147 156 <span type="species:ncbi:7955">zebrafish</span>
Germ-line transmission of a myocardium-specific GFP transgene reveals critical regulatory elements in the cardiac myosin light chain 2 promoter of zebrafish
###end article-title 118
###begin article-title 119
###xml 39 48 <span type="species:ncbi:7955">zebrafish</span>
Stages of embryonic development of the zebrafish
###end article-title 119
###begin article-title 120
###xml 20 29 <span type="species:ncbi:7955">zebrafish</span>
Proteomics of early zebrafish embryos
###end article-title 120
###begin article-title 121
###xml 15 24 <span type="species:ncbi:7955">zebrafish</span>
Foxd3 mediates zebrafish myf5 expression during early somitogenesis
###end article-title 121
###begin article-title 122
###xml 96 105 <span type="species:ncbi:7955">zebrafish</span>
Myogenic regulatory factors Myf5 and Myod function distinctly during craniofacial myogenesis of zebrafish
###end article-title 122
###begin article-title 123
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish genetics and vertebrate heart formation
###end article-title 123
###begin article-title 124
###xml 71 80 <span type="species:ncbi:7955">zebrafish</span>
Left-right pattern of cardiac BMP4 may drive asymmetry of the heart in zebrafish
###end article-title 124
###begin article-title 125
Left-right asymmetry and congenital cardiac defects: getting to the heart of the matter in vertebrate left-right axis determination
###end article-title 125
###begin article-title 126
The Wnt/beta-catenin pathway regulates cardiac valve formation
###end article-title 126
###begin article-title 127
GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides
###end article-title 127
###begin article-title 128
GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity
###end article-title 128
###begin article-title 129
Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium
###end article-title 129
###begin article-title 130
Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation
###end article-title 130
###begin article-title 131
Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3beta, and induction of the mitochondrial-dependent intrinsic caspase pathway
###end article-title 131
###begin article-title 132
A molecular mechanism for the effect of lithium on development
###end article-title 132
###begin article-title 133
Glycogen synthase kinase 3: an emerging therapeutic target
###end article-title 133
###begin article-title 134
Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
###end article-title 134
###begin article-title 135
Checkpoints of melanocyte stem cell development
###end article-title 135
###begin article-title 136
Wnt proteins are lipid-modified and can act as stem cell growth factors
###end article-title 136
###begin article-title 137
Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription
###end article-title 137
###begin article-title 138
Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells
###end article-title 138
###begin article-title 139
Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression
###end article-title 139
###begin article-title 140
Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death
###end article-title 140
###begin article-title 141
###xml 75 78 <span type="species:ncbi:10116">rat</span>
Activation of protein kinase B by adenosine A1 and A3 receptors in newborn rat cardiomyocytes
###end article-title 141
###begin article-title 142
Ectodermal Wnt3/beta-catenin signaling is required for the establishment and maintenance of the apical ectodermal ridge
###end article-title 142
###begin article-title 143
###xml 50 56 <span type="species:ncbi:10090">murine</span>
Multiple roles of mesenchymal beta-catenin during murine limb patterning
###end article-title 143
###begin article-title 144
###xml 29 38 <span type="species:ncbi:7955">zebrafish</span>
The heartstrings mutation in zebrafish causes heart/fin Tbx5 deficiency syndrome
###end article-title 144
###begin article-title 145
Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family
###end article-title 145
###begin article-title 146
Ventricular expression of tbx5 inhibits normal heart chamber development
###end article-title 146
###begin article-title 147
###xml 2 8 <span type="species:ncbi:10090">murine</span>
A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease
###end article-title 147
###begin article-title 148
Tbx5 and Tbx4 trigger limb initiation through activation of the Wnt/Fgf signaling cascade
###end article-title 148
###begin article-title 149
Organometallic compounds with biological activity: a very selective and highly potent cellular inhibitor for glycogen synthase kinase 3
###end article-title 149
###begin article-title 150
###xml 94 102 94 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 94 101 <span type="species:ncbi:8355">Xenopus</span>
Role of glycogen synthase kinase 3b as a negative regulator of dorsoventral axis formation in Xenopus embryos
###end article-title 150
###begin article-title 151
Regulation of Spemann organizer formation by the intracellular kinase Xgsk-3
###end article-title 151

